DNA Testing/Diagnostics Market Size, Share And Dynamics Till 2022

The Global DNA Testing/Diagnostics Market is anticipated to grow at a staggering CAGR in the forthcoming period. Diagnostic tests are the basis of a successful healthcare system that enables vital information about patients and healthcare providers necessary to land into right decisions.

The drivers for DNA Testing/Diagnostics market include demand for personalized medicine applications for chronic disorders is likely to propel the DNA Testing/Diagnostics market growth. Rise in demand for DNA Testing/Diagnostics for new born babies adds to the DNA Testing/Diagnostics market growth during the forecast period. In addition, genetic testing gains a higher traction to determine patient’s health at different stages of disease development fuels the market growth.

Browse Full Research Report @ 
https://www.millioninsights.com/industry-reports/dna-testing-diagnostics-market 

Product segment for DNA Testing/Diagnostics Market includes service & software, reagents and instruments. By technology, the DNA diagnostics market comprises in-situ hybridization, microarray, PCR, mass spectrometry and sequencing technology. Application segment for DNA testing industry include myogenic disorder and infectious disease. Infectious disease is segmented as Hepatitis B virus, Hepatitis C virus, TB, CT/NG. MRSA and HPV.

Myogenic disorder is further segmented as pre-implantation diagnostics and prenatal diagnostics. Geographical segmentation for DNA testing market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America holds a dominant share in the global DNA Testing/Diagnostics market owing to rise in adoption of DNA diagnostics technology and significant prevalence of chronic and infectious disease.

Asia-Pacific DNA Testing/Diagnostics market is anticipated to rise at a higher CAGR due to rise in research programs conducted by government in developing economies. Constant R&D and commercialization of technology for treatment of chronic diseases is likely to contribute to the market growth during the forecast period. The key players in the DNA Testing/Diagnostics industry include Cephide Inc., 454 Life Sciences, Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories, Hologic, GE Healthcare, Thermo Fisher Scientific, Illumina Inc., TransgenomicInc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, AlereInc, Affymetrix Inc., Agilent Technologies Inc., Dako, and Applied Biosystems Group.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/dna-testing-diagnostics-market/request-sample

Market Segment:

Global DNA Diagnostics/Testing Market Technology Outlook (Revenue, USD Million, 2012 – 2022)

• Microarrays based diagnostics
• PCR based diagnostics
• In-situ hybridization diagnostics
• NGS DNA diagnosis

Global DNA Diagnostics/Testing Market Application Outlook (Revenue, USD Million, 2012 – 2022)

• Prenatal DNA Carrier Screening
• Preimplantation Diagnosis
• Newborn Genetic Screening
• Infectious Disease Diagnostics
• HBV Diagnostic
• HCV Diagnostic
• HIV Diagnostic
• TB Diagnostic
• CT/NG Diagnostic
• HPV Diagnostic
• MRSA Diagnostic
• Others
• Oncology Diagnostics & Histopathology
• Identity Diagnostics & Forensics
• Pharmacogenomics Diagnostic Testing
• Drug Metabolism & P450 effects
• Others

DNA Diagnostics/Testing Market Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America

• U.S.
• Canada

Europe

• Germany
• UK

Asia Pacific

• Japan
• China

Latin America

• Brazil
• Mexico

MEA

• South Africa

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/biotechnology

For more details please visit @ Million Insights

Contact Details:
Company Name: Million Insights
Contact Person: Ryan Manuel
Phone: 91-20-65300184
Toll Free: 1-866-831-4085
Email:sales@millioninsights.com
Address: Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India